资讯
StockStory.org on MSN2 天
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
KLP Kapitalforvaltning AS bought a new stake in shares of First Advantage Co. (NYSE:FA – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities ...
Despite centuries of medical advancements, tuberculosis (TB) remains a formidable global health challenge. The World Health ...
SYDNEY, March 31, 2025 /PRNewswire/ — Webull Securities ( Australia) Pty Ltd (‘Webull Australia’), a subsidiary of Webull Corporation, the owner of the popular Webull trading platform, today announced ...
Full-body scans are making headlines for potentially catching diseases early, but some doctors urge caution. Here's what you ...
Guardant Health’s co-CEO, AmirAli Talasaz, expressed pride in the potential lifesaving impact of the Shield blood test for veterans and their families. This coverage decision by the VA represents a ...
Potbelly Corporation PBPB stock has witnessed a sharp decline of 20.3% in the past month compared with the industry and the S&P 500’s decrease of 3.7% and 3.2%, respectively. The recent decline ...
The Ghana Armed Forces Critical Care and Emergency Hospital (GAFCCEH), in partnership with the Ghana National Gas Limited, has organised a free kidney screening exercise and check-up at the 37 ...
5 commission-free trades (terms apply ... But, investing-focused brokers will be more likely to offer research and stock-screening tools as opposed to higher volumes of data and charting.
Barring an urgent intervention by the federal government, millions of Human Immunodeficiency Virus (HIV) and Tuberculosis (TB ...
Here's what to know about each program — and how to get them for free or at a discounted rate. Thanks to biometric identification (via fingerprint or iris scans), Clear users typically do not have to ...
Envestnet Portfolio Solutions Inc. lessened its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 10.6% ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果